平板电脑家庭监测在年龄相关性黄斑变性中的短期依从性与门诊测试一致性
本研究纳入73例中间型年龄相关性黄斑变性(iAMD)患者,训练其使用Melbourne Rapid Fields-macular(MRF-m)iPad应用进行家庭黄斑视网膜敏感度(RS)监测,要求每周返回6次测试。59例完成6次家庭检查,每周测试依从性为55%,主要障碍为信息技术(IT)后勤原因;694次家庭检查中96%可靠,平板电脑平均RS较MaIA微视野计高3.2 dB(P < .05)。
要点
- iAMD患者每周家庭监测依从性为55%,主要障碍为IT后勤问题。
- 96%的家庭检查结果可靠(假阳性<25%)。
- 平板电脑测得RS较MaIA高3.2 dB(P < .05),差异源于测试设计。
核心结论
- 家庭监测产生可靠结果,但因测试设计不同而与门诊测试存在差异。
- 建立家庭基线后此差异不应影响自我监测,但会影响与门诊结果的比较。
- 每周测试依从性尚可,改善IT支持可能提高依从性。
研究设计与样本
- 单中心纵向依从性与可靠性研究。
- 纳入73例中间型年龄相关性黄斑变性(iAMD)参与者,训练其使用MRF-m iPad应用进行黄斑视野测试。
- 要求志愿者在家每周返回6次测试,由音频指导。
- 评估每周测试依从性并调查限制依从性的因素。
- 将测试可靠性(假阳性、假阴性)和RS与门诊MaIA微视野计比较。
主要发现
- 59例参与者提交6次家庭检查,中位测试间隔为8.0 [7.0-17]天。
- 每周测试(7天±24小时)依从性为55%。
- 限制依从性的主要障碍为信息技术(IT)后勤原因。
- 694次家庭检查中96%可靠(假阳性结果<25%)。
- 平板电脑返回的平均RS较MaIA显著更高(+3.2 dB,P < .05)。
关键数值与推荐
- 每周测试依从性定义为7天±24小时,依从性为55%。
- 可靠性定义为假阳性结果<25%,96%的家庭检查可靠。
- 平板电脑平均RS较MaIA高3.2 dB(P < .05)。
临床怎么用
- iAMD患者可在家使用平板电脑进行黄斑视网膜敏感度自我监测,结果可靠。
- 建立家庭基线后,家庭监测结果可用于自我监测,但不应直接与门诊MaIA结果比较。
- 改善IT支持可能提高家庭监测依从性。
局限性
- 单中心研究,样本量有限(73例参与者,59例完成6次家庭检查)。
- 短期随访(6周),依从性结果可能不适用于长期监测。
- 未报告假阴性结果的具体数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to determine the short-term compliance with regular home monitoring of macular retinal sensitivity (RS) in intermediate age-related macular degeneration (iAMD). Home-based outcomes were compared with in-clinic outcomes determined using (1) the same tablet device under supervision, and (2) the Macular Integrity Assessment (MaIA) microperimeter. DESIGN: Single-center longitudinal compliance and reliability study. METHODS: A total of 73 participants with iAMD were trained to perform macular field testing with the Melbourne Rapid Fields-macular (MRF-m) iPad application. Volunteers were asked to return 6 weekly tests from home, guided by audio instructions. We determined compliance with weekly testing and surveyed for factors that limited compliance. Test reliability (false positive, false negative) and RS were compared to in-clinic assays (MaIA). Data are given as mean ± SD or as median [quartile 1-3 range]. Group comparisons were achieved with bootstrap to define the 95% confidence limits. RESULTS: A total of 59 participants submitted 6 home examinations with a median intertest interval of 8.0 [7.0-17] days. Compliance with weekly testing (7 days ±24 hours) was 55%. The main barrier to compliance was information technology (IT) logistic reasons. Of 694 home examinations submitted, 96% were reliable (false-positive results <25%). The mean RS returned by the tablet was significantly higher (+3.2 dB, P < .05) compared to the MaIA. CONCLUSIONS: Home monitoring produces reliable results that differ from in-clinic tests because of test design. This should not affect self-monitoring once an at-home baseline is established, but these differences will affect comparisons with in-clinic outcomes. Reasonable compliance with weekly testing was achieved. Improved IT support might lead to better compliance.
引用
- Prea SM, Kong GYX, Guymer RH, et al. The Short-Term Compliance and Concordance to in Clinic Testing for Tablet-Based Home Monitoring in Age-Related Macular Degeneration. Am J Ophthalmol. 2021. PMID: 34509437. doi:10.1016/j.ajo.2021.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。